Relationship of BMI and Parity with High Grade Serous Ovarian Cancer at RSUP Dr. M. Djamil Padang
DOI:
https://doi.org/10.25077/aoj.9.2.259-266.2025Keywords:
Body Mass Index, Parity, Ovarian Cancer, HGSCAbstract
Introduction : Ovarian cancer is the 8th most common cancer in women. High grade serous carcinoma (HGSC) is a subtype of ovarian cancer with the highest case and death rate compared to other types. Therefore, a preventive approach is needed by reviewing the underlying risk factors of this cancer. Body mass index (BMI) and parity are modifiable risk factors for ovarian cancer. This study aims to determine the relationship BMI and parity on high grade serous subtype ovarian cancer at RSUP Dr. M. Djamil Padang.
Method: observational analytic study with a cross sectional approach. This research was conducted at RSUP Dr. M. Djamil Padang using medical record data of epithelial ovarian cancer patients at RSUP Dr. M. Djamil Padang from 2021 to 2022 with a sample of 129 patients. The data analysis method used in this research is the Chi-square test.
Result : Epithelial ovarian cancer patients are most found at >50 years old (55%), menopausal woman (65.9%), non obese (77.5%) and parous women (76%).
Conclusion : There was no relationship between body mass index and parity with the incidence of ovarian cancer, subtype high grade serous, at RSUP Dr. M. Djamil Padang.
References
1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209-249.
2. Kurman R.J. Carcangiu ML, Herrington CS, Young RH. Tumours of the ovary. In: WHO Classification of tumours of female reproductive organs. 04th ed. France: Lyon: IARC; 2014:1-34.
3. Ravindran F, Choudhary B. Ovarian cancer: molecular classification and targeted therapy. Ovarian Cancer - Updates in Tumour Biology and Therapeutics. IntechOpen; 2021:2-3.
4. Kim J, Park EY, Kim O, Schilder JM, Coffey DM, Cho CH, Bast RC. Cell origins of high grade serous ovarian cancer. Cancers (Basel). 2018;10(11):1-28.
5. Gaitskell K, Hermon C, Barnes I, Pirie K, Floud S, Green J, et. al. Ovarian cancer survival by stage, histotype, and prediagnostic lifestyle factors, in the prospective UK million women study. Cancer Epidemiol. 2022;76:1-8.
6. Pinto P, Burgetova A, Cibula D, Haldorsen IS, Indrielle-Kelly T, Fischerova D. Prediction of surgical outcome in advanced ovarian cancer by imaging and laparoscopy: A narrative review. Cancers (Basel). 2023;15(6):1904-1933.
7. Hoare JI, Hockings H, Saxena J, Silva VL, Maniati E, Mirza HB, et al. Platinum resistance induces diverse evolutionary trajectories in high grade serous ovarian cancer. bioRxiv.2020:1-20.
8. Elshami M, Tuffaha A, Yaseen A, et al. Awareness of ovarian cancer risk and protective factors: A national cross-sectional study from Palestine. PLoS One. 2022;17:1-14.
9. Colozza D & Padmita AC. Analisis lanskap kelebihan berat badan & obesitas di Indonesia. Jakarta: UNICEF; 2019:26-35.
10. Yang J, Zaman MM, Vlasakov I, et al. Adipocytes promote ovarian cancer chemoresistance. Sci Rep. 2019;9(1):1-12.
11. Ding N, Zhan J, Shi Y, Qiao T, Li P, Zhang T. Obesity in children and adolescents and the risk of ovarian cancer: A systematic review and dose response meta-analysis. PLoS One. 2022;17(12):1-14.
12. Toufakis V, Katuwal S, Pukkala E, Tapanainen JS. Impact of parity on the incidence of ovarian cancer subtypes: a population based case control study. Acta Oncol (Madr). 2021;60(7):850-855.
13. Salehiniya Hamid. Is pregnancy characteristic associated with ovarian cancer? A review of the available evidence. Eurasian J Med Oncol. 2022;6(3):198-209.
14. Mahyenda N, Muhammad S, Asri A. Hubungan skor RMI dengan stadium kanker ovarium tipe epitel di RSUP Dr. M. Djamil Padang. J Ilmu Kesehat Indones. 2023;3(3):210-216.
15. Yi M, Li T, Niu M, Luo S, Chu Q, Wu K. Epidemiological trends of women’s cancers from 1990 to 2019 at the global, regional, and national levels: a population-based study. Biomark Res. 2021;9(1):1-12.
16. Irsan B, Pradjatmo H, Lutfi M. Hubungan antara modified glasgow prognostic score (mGPS) dengan stadium dan derajat diferensiasi kanker ovarium. J Kesehat Reproduksi. 2021;7(3):160.
17. Handoko AL, Jayadi T, Putra ERK, Kusumosih TAR. Hubungan antara obesitas dengan kanker ovarium di Rumah Sakit Bethesda Yogyakarta. J Kedokt Meditek. 2023;29(1):27-33.
18. Winarto H, Habiburrahman M, Febriana IS, Kusuma F, Nuryanto KH, Anggraeni TD, et al. Is there any difference in insulin resistance status between cases of benign and malignant ovarian neoplasms? A study on surrogate markers of insulin resistance in Indonesian non-diabetic women. Oncol Lett. 2023;25(1):1-18.
19. Mediano MFF, Sichieri R. Insulin resistance influences weight loss in non-obese women who followed a home-based exercise program and slight caloric restriction. Diabetes Res Clin Pract. 2011;92(3):361-367.
20. Simamora RPA, Hanriko R, Sari RDP. Hubungan usia , jumlah paritas , dan usia menarche terhadap derajat histopatologi kanker ovarium di RSUD Dr . H . Abdul Moeloek Bandar Lampung tahun 2015-2016. Majority. 2018;7(2):7-13.
21. Sköld C, Bjørge T, Ekbom A, Engeland A, Gissler M, Grotmol T, et al. Preterm delivery is associated with an increased risk of epithelial ovarian cancer among parous women. Int J Cancer. 2018;143(8):1858-1867.
22. Fortner RT, Rice MS, Knutsen SF, Orlich MJ, Visvanathan K, Patel AV, et al. Ovarian cancer risk factor associations by primary anatomic site: The ovarian cancer cohort consortium. Cancer Epidemiol Biomarkers Prev. 2020;29(10):2010-2018.
23. Nishikawa H, Goto M, Fukunishi S, Asai A, Nishiguchi S, Higuchi K. Cancer cachexia: Its mechanism and clinical significance. Int J Mol Sci. 2021;22(16):8491.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Thanya Amoret Alyaa Murizal
This work is licensed under a Creative Commons Attribution 4.0 International License.
